To view or listen to our most recent corporate presentations, please use the link provided below

Click here for recent conferences and presentations

Incyte's INCB18424 ASH 2008 Poster Information

Click here to view poster information

Incyte Reports Progress in Multiple Clinical Program; Announces Third Quarter Financial Results

Click here to view press release

Incyte's JAK Inhibitor Demonstrates Rapid and Marked Clinical Improvement in Rheumatoid Arthritis Patients

Click here to view press release

Product Pipeline - Learn more about our drug discovery programs.

Incyte's Clinical Trials
To learn more about Incyte's ongoing clinical trials, please go to the following links:

INCB18424: Myelofibrosis http://www.clinicaltrials.gov/ct2/show/NCT00509899

INCB18424: Polycythemia vera/Essential Thrombocytopenia http://www.clinicaltrials.gov/ct2/show/NCT00726232

INCB18424: Multiple myeloma http://www.clinicaltrials.gov/ct2/show/NCT00639002

INCB18424: Topical psoriasis http:://www.clinicaltrials.gov/ct2/show/NCT00617994

INCB13739: Type2 Diabetes(11BETA-HSD1)http://www.clinicaltrials.gov/ct2/show/NCT00698230

INCB19602: Type2 Diabetes(HM74a)http://www.clinicaltrials.gov/ct2/show/NCT00698789